Source:http://linkedlifedata.com/resource/pubmed/id/16584668
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2006-4-4
|
pubmed:abstractText |
Dendritic cell (DC)-based vaccination against cancer is a specific immunotherapy with a new therapeutic approach for patients with cancer. Preclinical and clinical trials, in which more than 1,000 cancer patients received dendritic cell vaccination, have shown that it is possible to activate the immune system against cancer cells and to induce a clinical response in some of the patients. The treatment is so far experimental, and there is a need for well-designed trials that aim to improve the DC vaccine approach.
|
pubmed:language |
dan
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1603-6824
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
168
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1415-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16584668-Cancer Vaccines,
pubmed-meshheading:16584668-Combined Modality Therapy,
pubmed-meshheading:16584668-Dendritic Cells,
pubmed-meshheading:16584668-Female,
pubmed-meshheading:16584668-Humans,
pubmed-meshheading:16584668-Lymphocyte Activation,
pubmed-meshheading:16584668-Male,
pubmed-meshheading:16584668-Neoplasms,
pubmed-meshheading:16584668-T-Lymphocytes,
pubmed-meshheading:16584668-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Dendrite cell-based cancer vaccines--clinical application].
|
pubmed:affiliation |
Amtssygehuset i Herlev, Onkologisk og Haematologisk Afdeling, og Københavns Universitet, Panum Instituttet, Herlev. inge.m.svane@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|